Structured Abstract

Contents

• Preface
• Acknowledgments
• Key Informants
• Technical Expert Panel
• Peer Reviewers
• Executive Summary
• Introduction
  • Background
  • Purpose for Evidence Report
  • Key Questions
• Methods
  • Topic Development
  • Analytic Framework
  • Study Selection
  • Screening and Diagnostic Device Descriptions
  • Search Strategy
  • Abstract Screening
  • Full-Text Screening
  • Data Abstraction
  • Risk of Bias Assessment
  • Rating of Evidence
  • Data Synthesis
• Results
  • Key Question 1
  • Key Question 2
  • Key Question 3
  • Key Question 4
  • Key Question 5
  • Key Question 6
• Discussion
• Future Research Needs
  • Does Screening for Glaucoma Alter Either Intermediate or Final Outcomes?
  • What Tests or Devices are Best Able To Identify People With Glaucoma in a Screening Setting?
  • Are There Groups in Which Screening Might be More Effective?
  • Are There Stages of Disease at Which Screening is More Appropriate?
• References
• Abbreviations
• Appendixes
  • Appendix A Search Strategy
  • Appendix B Screening and Data Abstraction Forms
  • Appendix C Evidence Tables
  • Appendix D ICD-9 Classification
  • Appendix E Excluded Articles
  • Appendix F Included Devices

Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services¹, Contract No. 290-2007-10061, Prepared by: Johns Hopkins University Evidence-based Practice Center, Baltimore, MD

Suggested citation:

Ervin AM, Boland MV, Myrowitz EH, Prince J, Hawkins B, Vollenweider D, Ward D, Suarez-Cuervo C, Robinson KA. Screening for Glaucoma: Comparative Effectiveness. Comparative Effectiveness Review No. 59. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-2007-10061.) AHRQ Publication No. 12-EHC037-EF. Rockville, MD: Agency for Healthcare Research and Quality. April 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

This report is based on research conducted by the Johns Hopkins University Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2007-10061). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients.

This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report.

1

540 Gaither Road, Rockville, MD 20850; www​.ahrq.gov